Dan Chen

Chief Financial Officer at Retrace and Senior Advisor and Mentor in the Healthcare and Technology Sectors

Dan Chen is a Senior Advisor at Arctoris, a company specializing in in-vitro pre-clinical R&D lab services that utilize AI and machine learning to enhance drug discovery processes. He has been with Arctoris since March 2023, contributing his extensive experience in private equity, investment banking, and corporate finance to the organization.1 2

Professional Background

Dan Chen has over 24 years of experience in various roles across different sectors. Before joining Arctoris, he served as the Chief Financial Officer at Retrace, where he focused on AI-driven healthcare solutions. His previous positions include Managing Director at CEC Capital, where he led cross-border M&A and capital raising efforts, and roles at Siemer & Associates and Montgomery & Co., where he was involved in significant transactions in the media and technology sectors.1 3

Education

Dan Chen holds a degree from Yale University, which complements his extensive professional background in finance and corporate strategy.1

Current Roles

In addition to his role at Arctoris, he is also an Advisory Board Member at Senseer Health Inc. and an investor at Atomo Coffee, showcasing his involvement in both healthcare technology and sustainable consumer products.1 3

Experience

Chief Financial Officer at Retrace (July 2023 - Present)

Senior Advisor at Arctoris (March 2023 - Present), Advisory Board Member at Senseer Health Inc. (March 2023 - Present), Mentor at Mucker Capital (January 2013 - Present), Managing Director – Head of US Office and Technology, Media & Telecom Group at CEC Capital (September 2016 - August 2022)